Aequus Pharmaceuticals

14 articles about Aequus Pharmaceuticals

• Aequus and reVision to Collaborate on Stargardt Disease Program

  8/17/2021

  Aequus Pharmaceuticals Inc. and reVision Therapeutics, Inc. announce a collaboration on the development of a therapy for Stargardt disease.

• 

  BioSpace Global Roundup, Oct. 22

  10/22/2020

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
• 

  BioSpace Global Roundup, Sept. 24

  9/24/2020

  Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
• 

  BioSpace Global Roundup, Sept. 3

  9/3/2020

  Biopharma and life science companies from across the globe provide updates on their pipelines and businesses.

• CannaRoyalty and Aequus Pharma Announce Joint Venture to Develop and Commercialize Cannabis-Based Therapies Targeting Neurological Disorders

  1/11/2018

  CannaRoyalty and Aequus today announced a collaboration to advance a suite of cannabis-based therapies targeting neurological disorders into clinical trials in Canada, in collaboration with Canadian doctors and key opinion leaders.

• Aequus Pharmaceuticals Announces Positive Results For Proof Of Concept Clinical Trial Of Anti-Nausea Patch

  9/8/2017

• Aequus Pharmaceuticals And CDRD Announce Research Collaboration To Improve Cannabinoid-Based Therapeutics

  6/1/2017

• Aequus Pharmaceuticals Announces Positive Results From Second Proof Of Concept Study For Long-Acting Aripiprazole Transdermal Patch

  4/3/2017

• Aequus Pharmaceuticals Licenses Canadian Commercialization Rights To Trokendi XR And Oxtellar XR From Supernus

  2/16/2016

• Aequus Pharmaceuticals To Present At Noble Capital Markets' Investor Conference

  1/18/2016

• Aequus Pharmaceuticals And Corium International, Inc. Enter Into Product Development Collaboration Focused On CNS

  4/29/2015

• Aequus Pharmaceuticals Receives Conditional Approval To Commence Trading On TSX-V Exchange

  3/11/2015

• Aequus Pharmaceuticals Becomes Reporting Issuer

  2/23/2015

• Aequus Pharmaceuticals Closes $4.2 Million Private Placement Financing

  11/20/2014